Lactitol

拉克替醇

Report date: 2022/02/24 13:58:18
NME

Base Information

Drug NameLactitol
Drug Alias Name乳梨醇Lactitolum乳糖醇PortolacImportal +[9] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsConstipationHyperammonemiaLiver Cirrhosis +[4] 
Global Approved IndicationsConstipationHyperammonemiaLiver Cirrhosis +[4] 
Approved Indications in ChinaConstipationHepatic Encephalopathy
Original Approved Country/TerritoryN/A
Original Approved Date1985/01/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBraintree Laboratories IncLianyungang Runzhong Pharmaceutical Co LtdNippon Shinyaku Co Ltd
Inactive CompaniesN/A
Active IndicationsConstipationHyperammonemiaLiver Cirrhosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA06AD12
Related LinksWikipediaKEGG